Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in renovascular hypertension

被引：0
|
作者：
Gao, J. [1 ]
Gomez, E. [1 ]
Henry, J. P. [1 ]
Dautreaux, B. [1 ]
Bounoure, F. [3 ]
Skiba, M. [3 ]
Thuillez, C. [1 ,2 ]
Bellien, J. [1 ,2 ]
Richard, V. [1 ,2 ]
机构：
[1] INSERM, U644, F-75654 Paris 13, France
[2] Rouen Univ Hosp, Dept Pharmacol, Inst Biomed Res, Rouen, France
[3] Univ Rouen, ADEN EA 3234, Galen Lab, F-76821 Mont St Aignan, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
100
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [21] Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy
    Kim, Jinu
    Yoon, Sang Pil
    Toews, Myron L.
    Imig, John D.
    Hwang, Sung Hee
    Hammock, Bruce D.
    Padanilam, Babu J.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2015, 308 (02) : F131 - F139
  • [22] Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats
    Leuillier, Matthieu
    Platel, Valentin
    Tu, Ly
    Feugray, Guillaume
    Thuillet, Raphael
    Groussard, Deborah
    Messaoudi, Hind
    Ottaviani, Mina
    Chelgham, Mustapha
    Nicol, Lionel
    Mulder, Paul
    Humbert, Marc
    Richard, Vincent
    Morisseau, Christophe
    Brunel, Valery
    Duflot, Thomas
    Guignabert, Christophe
    Bellien, Jeremy
    CELLS, 2023, 12 (04)
  • [23] Antioxidant Treatment With Tempol and Apocynin Prevents Endothelial Dysfunction and Development of Renovascular Hypertension
    Costa, Cristiane A.
    Amara, Taline A. S.
    Carvalho, Lenize C. R. M.
    Ognibene, Dayane T.
    da Silva, Andrea F. E.
    Moss, Monique B.
    Valenca, Samuel S.
    de Moura, Roberto S.
    Resende, Angela C.
    AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 (12) : 1242 - 1249
  • [24] Inhibition of Soluble Epoxide Hydrolase for Renal Health
    Liu, Jun-Yan
    FRONTIERS IN PHARMACOLOGY, 2019, 9
  • [25] Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides
    Morisseau, Christophe
    Pakhomova, Svitlana
    Hwang, Sung Hee
    Newcomer, Marcia E.
    Hammock, Bruce D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (13) : 3818 - 3821
  • [26] Inhibition of soluble epoxide hydrolase by natural isothiocyanates
    Elbarbry, Fawzy
    Espiritu, Michael J.
    Soo, Kaylen
    Yee, Baily
    Taylor, Jonathan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 725
  • [27] Inhibition of the Soluble Epoxide Hydrolase by Tyrosine Nitration
    Barbosa-Sicard, Eduardo
    Froemel, Timo
    Keserue, Benjamin
    Brandes, Ralf P.
    Morisseau, Christophe
    Hammock, Bruce D.
    Braun, Thomas
    Krueger, Marcus
    Fleming, Ingrid
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (41) : 28156 - 28163
  • [28] Inhibition of soluble epoxide hydrolase as a therapeutic approach for blood-brain barrier dysfunction
    Li, Shuo
    Song, Huijia
    Sun, Yanping
    Sun, Yongjun
    Zhang, Huimin
    Gao, Zibin
    BIOCHIMIE, 2024, 223 : 13 - 22
  • [29] Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction
    Savina, Yann
    Duflot, Thomas
    Bounoure, Frederic
    Kotzki, Sylvain
    Thiebaut, Pierre-Alain
    Serreau, Pierre-Alex
    Skiba, Mohamed
    Picquenot, Jean-Michel
    Cornic, Marie
    Morisseau, Christophe
    Hammock, Bruce
    Imbert, Laurent
    Cracowski, Jean-Luc
    Richard, Vincent
    Roustit, Matthieu
    Bellien, Jeremy
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (06): : 523 - 529
  • [30] Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
    Imig, JD
    Zhao, XY
    Capdevila, JH
    Morisseau, C
    Hammock, BD
    HYPERTENSION, 2002, 39 (02) : 690 - 694
12345